Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Bioanalysis
|
June 16, 2016
Old to new ligand-binding assay method modifications
Bruce Stouffer, Dennis Stocker
Bioanalysis
|
November 10, 2018
Incurred sample reproducibility in pharmacokinetic bioanalysis: pros and cons from a CRO perspective
Brittany Maria Timmons, Laura Hay, Jim Gorman, et al.
Journal of Drug Targeting
|
May 9, 2002
Effect of delivery route on pulmonary response to oncostatin M
Hong Lan Li, Neil Mathias, Julita Timoszyk, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
October 11, 2011
A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study
Michael T Furlong, Shruti Agrawal, Dara Hawthorne, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
June 20, 2012
A validated enantioselective LC-MS/MS assay for the simultaneous determination of carvedilol and its pharmacologically active 4'-hydroxyphenyl metabolite in human plasma: application to a clinical pharmacokinetic study
Michael T Furlong, Bing He, William Mylott, et al.
Bioanalysis
|
December 23, 2014
Quantitative determination of free/bound atazanavir via high-throughput equilibrium dialysis and LC-MS/MS, and the application in ex vivo samples
Xiaohui Sophia Xu, Anne Rose, Roger Demers, et al.
Bioanalysis
|
December 22, 2012
Fit-for-purpose bioanalytical cross-validation for LC-MS/MS assays in clinical studies
Xiaohui Xu, Qin C Ji, Mohammed Jemal, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 20, 2010
Liquid chromatography and tandem mass spectrometry for the quantitative determination of ixabepilone (BMS-247550, Ixempra) in human plasma: method validation, overcoming curve splitting issues and eliminating chromatographic interferences from degradants
Xiaohui Sophia Xu, Jianing Zeng, William Mylott, et al.
Bioanalysis
|
June 2, 2012
Validation and life-cycle management of a quantitative ligand-binding assay for the measurement of Nulojix(®), a CTLA-4-Fc fusion protein, in renal and liver transplant patients
Heather A Myler, Kelli R Phillips, Huijin Dong, et al.
Journal of Immunological Methods
|
July 4, 2012
Addressing drug effects on cut point determination for an anti-drug antibody assay
Maria D F S Barbosa, Carol R Gleason, Kelli R Phillips, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Bioanalysis
|
June 16, 2016
Old to new ligand-binding assay method modifications
Bruce Stouffer, Dennis Stocker
Bioanalysis
|
November 10, 2018
Incurred sample reproducibility in pharmacokinetic bioanalysis: pros and cons from a CRO perspective
Brittany Maria Timmons, Laura Hay, Jim Gorman, et al.
Journal of Drug Targeting
|
May 9, 2002
Effect of delivery route on pulmonary response to oncostatin M
Hong Lan Li, Neil Mathias, Julita Timoszyk, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
October 11, 2011
A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study
Michael T Furlong, Shruti Agrawal, Dara Hawthorne, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
June 20, 2012
A validated enantioselective LC-MS/MS assay for the simultaneous determination of carvedilol and its pharmacologically active 4'-hydroxyphenyl metabolite in human plasma: application to a clinical pharmacokinetic study
Michael T Furlong, Bing He, William Mylott, et al.
Bioanalysis
|
December 23, 2014
Quantitative determination of free/bound atazanavir via high-throughput equilibrium dialysis and LC-MS/MS, and the application in ex vivo samples
Xiaohui Sophia Xu, Anne Rose, Roger Demers, et al.
Bioanalysis
|
December 22, 2012
Fit-for-purpose bioanalytical cross-validation for LC-MS/MS assays in clinical studies
Xiaohui Xu, Qin C Ji, Mohammed Jemal, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 20, 2010
Liquid chromatography and tandem mass spectrometry for the quantitative determination of ixabepilone (BMS-247550, Ixempra) in human plasma: method validation, overcoming curve splitting issues and eliminating chromatographic interferences from degradants
Xiaohui Sophia Xu, Jianing Zeng, William Mylott, et al.
Bioanalysis
|
June 2, 2012
Validation and life-cycle management of a quantitative ligand-binding assay for the measurement of Nulojix(®), a CTLA-4-Fc fusion protein, in renal and liver transplant patients
Heather A Myler, Kelli R Phillips, Huijin Dong, et al.
Journal of Immunological Methods
|
July 4, 2012
Addressing drug effects on cut point determination for an anti-drug antibody assay
Maria D F S Barbosa, Carol R Gleason, Kelli R Phillips, et al.
Page
of 3